Shares of Fortis Healthcare gained 2.06% to trade at Rs 948.90 on Wednesday. The stock is a constituent of the Nifty Midcap 150 index.
On the financial front, Fortis Healthcare has demonstrated strong performance both on a quarterly and annual basis. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,166.72 Crore, up from Rs 1,858.90 Crore in June 2024. The net profit for the same period was Rs 263.86 Crore, compared to Rs 173.39 Crore in the previous year.
The annual consolidated revenue for the year-ending March 2025 reached Rs 7,782.75 Crore, a notable increase from Rs 6,892.92 Crore in March 2024. The net profit also saw an increase, rising to Rs 797.86 Crore in March 2025 from Rs 635.71 Crore in March 2024.
Key financial data is summarized below:
| Financials (Consolidated) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue (Rs Crore) | 4,030.12 | 5,717.61 | 6,297.63 | 6,892.92 | 7,782.75 |
| Net Profit (Rs Crore) | -103.73 | 765.80 | 611.15 | 635.71 | 797.86 |
| EPS | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
| BVPS | 88.98 | 92.83 | 107.30 | 113.33 | 118.11 |
| ROE | -1.79 | 8.98 | 8.12 | 7.81 | 8.68 |
| Debt to Equity | 0.19 | 0.16 | 0.10 | 0.11 | 0.25 |
| Income Statement (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 4,030 | 5,717 | 6,297 | 6,892 | 7,782 |
| Other Income | 46 | 27 | 61 | 38 | 66 |
| Total Income | 4,076 | 5,744 | 6,359 | 6,931 | 7,849 |
| Total Expenditure | 3,915 | 4,634 | 5,438 | 5,951 | 6,669 |
| EBIT | 161 | 1,110 | 920 | 979 | 1,179 |
| Interest | 165 | 146 | 129 | 130 | 184 |
| Tax | 99 | 197 | 180 | 212 | 197 |
| Net Profit | -103 | 765 | 611 | 635 | 797 |
| Cash Flow (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating Activities | 485 | 865 | 822 | 1,100 | 1,423 |
| Investing Activities | -135 | -514 | -373 | -886 | -779 |
| Financing Activities | -142 | -517 | -471 | -86 | -713 |
| Others | 4 | 13 | 1 | -2 | 0 |
| Net Cash Flow | 212 | -152 | -21 | 124 | -69 |
| Balance Sheet (Rs Crore) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Share Capital | 754 | 754 | 754 | 754 | 754 |
| Reserves & Surplus | 5,362 | 5,423 | 6,485 | 6,906 | 8,161 |
| Current Liabilities | 1,233 | 1,269 | 1,425 | 3,170 | 1,607 |
| Other Liabilities | 3,803 | 4,437 | 3,767 | 2,457 | 3,167 |
| Total Liabilities | 11,154 | 11,884 | 12,433 | 13,288 | 13,691 |
| Fixed Assets | 5,242 | 5,485 | 5,513 | 6,221 | 6,636 |
| Current Assets | 1,036 | 1,133 | 1,406 | 1,420 | 1,471 |
| Other Assets | 4,875 | 5,265 | 5,514 | 5,646 | 5,584 |
| Total Assets | 11,154 | 11,884 | 12,433 | 13,288 | 13,691 |
| Contingent Liabilities | 1,936 | 2,607 | 2,834 | 2,999 | 3,136 |
| Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
| Diluted Eps (Rs.) | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
| Book Value /Share (Rs.) | 88.98 | 92.83 | 107.30 | 113.33 | 118.11 |
| Dividend/Share (Rs.) | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 |
| Face Value | 10 | 10 | 10 | 10 | 10 |
| Gross Profit Margin (%) | 11.19 | 19.17 | 18.46 | 18.94 | 21.26 |
| Operating Margin (%) | 3.98 | 13.91 | 13.45 | 13.97 | 16.30 |
| Net Profit Margin (%) | -2.57 | 13.39 | 9.70 | 9.22 | 10.25 |
| Return on Networth / Equity (%) | -1.79 | 8.98 | 8.12 | 7.81 | 8.68 |
| ROCE (%) | 1.61 | 7.49 | 7.69 | 9.52 | 10.50 |
| Return On Assets (%) | -0.98 | 4.67 | 4.73 | 4.50 | 5.65 |
| Current Ratio (X) | 0.84 | 0.89 | 0.99 | 0.45 | 0.92 |
| Quick Ratio (X) | 0.78 | 0.80 | 0.90 | 0.41 | 0.84 |
| Debt to Equity (x) | 0.19 | 0.16 | 0.10 | 0.11 | 0.25 |
| Interest Coverage Ratios (X) | 0.97 | 7.47 | 9.01 | 9.97 | 8.97 |
| Asset Turnover Ratio (%) | 36.12 | 0.08 | 0.09 | 0.54 | 0.58 |
| Inventory Turnover Ratio (X) | 52.50 | 0.00 | 0.00 | 0.00 | 69.89 |
| 3 Yr CAGR Sales (%) | -6.00 | 13.11 | 16.60 | 30.78 | 16.67 |
| 3 Yr CAGR Net Profit (%) | -67.59 | 14.11 | 177.58 | 147.56 | 2.07 |
| P/E (x) | -137.34 | 39.51 | 33.32 | 52.99 | 68.07 |
| P/B (x) | 2.45 | 3.55 | 2.71 | 4.14 | 5.91 |
| EV/EBITDA (x) | 36.26 | 21.26 | 17.90 | 25.16 | 33.04 |
| P/S (x) | 3.73 | 3.83 | 3.12 | 4.60 | 6.78 |
Moneycontrol analysis indicates a very bullish sentiment for the stock.
With the stock currently trading at Rs 948.90, Fortis Healthcare has shown a positive trend in Wednesday's session, driven by strong financial performance and dividend announcements.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
